SPECTRUM BRANDS - RAYOVAC

Lobbying Spend

—

Filings

Firms Hired

Active Period

2009–2018

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2018	—	4	1
2017	—	5	1
2016	—	4	1
2015	—	4	1
2014	—	4	1
2013	—	5	1
2012	—	4	1
2011	—	5	1
2010	—	5	1
2009	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAPSTONE NATIONAL PARTNERS	—	43

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	33
SENATE	33
Defense, Dept of (DOD)	10
Food & Drug Administration (FDA)	10
State, Dept of (DOS)	10
Veterans Affairs, Dept of (VA)	4

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	16
Budget/Appropriations	Budget/Appropriations	13
Veterans	Veterans	4
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	2
Science/Technology	Science/Technology	1

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3326110th Congress

Early Treatment for HIV Act of 2007

2009 · fourth_quarter · Firm: CAPSTONE NATIONAL PARTNERS

Cited source text and reported amounts

FY10 Department of Defense Appropriations Bill (H.R. 3326), Funding for Research and Development Projects

Client expense: — · Firm income: $20,000

Matched citations: H.R. 3326

H.R. 3326110th Congress

Early Treatment for HIV Act of 2007

2009 · third_quarter · Firm: CAPSTONE NATIONAL PARTNERS

Cited source text and reported amounts

FY10 Department of Defense Appropriations Bill (H.R. 3326), Funding for Research and Development Projects

Client expense: — · Firm income: $10,000

Matched citations: H.R. 3326

SPECTRUM BRANDS - RAYOVAC — Lobbying Disclosure | Poliscope